Patents by Inventor Wesley H. Dehaan

Wesley H. Dehaan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhalable dry powders
    Patent number: 11235112
    Abstract: The invention related to dry powders that contain a therapeutic agent. The dry powders have characteristics, e.g., they are processable and/or dense in therapeutic agent that provide advantages for formulating and delivering therapeutics agents to patients.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: February 1, 2022
    Assignee: Pulmatrix Operating Company, Inc.
    Inventors: Wesley H. DeHaan, Jean C. Sung, Diana Manzanedo, Ciaran Lawlor, Michael Tauber
  • INHALABLE DRY POWDERS
    Publication number: 20210060268
    Abstract: The invention related to dry powders that contain a therapeutic agent. The dry powders have characterstics, e.g., they are processable and/or dense in therapeutic agent that provide advantages for formulating and delivering therapeutics agents to patients.
    Type: Application
    Filed: September 15, 2020
    Publication date: March 4, 2021
    Inventors: Wesley H. DeHaan, Jean C. Sung, Diana Manzanedo, Ciaran Lawlor, Michael Tauber
  • Inhalable dry powders
    Patent number: 10806871
    Abstract: The invention related to dry powders that contain a therapeutic agent. The dry powders have characteristics, e.g., they are processable and/or dense in therapeutic agent that provide advantages for formulating and delivering therapeutic agents to patients.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: October 20, 2020
    Assignee: Pulmatrix Operating Company, Inc.
    Inventors: Wesley H. DeHaan, Jean C. Sung, Diana Manzanedo, Ciaran Lawlor, Michael Tauber
  • INHALABLE DRY POWDERS
    Publication number: 20200261667
    Abstract: The invention related to dry powders that contain a therapeutic agent. The dry powders have characteristics, e.g., they are processable and/or dense in therapeutic agent that provide advantages for formulating and delivering therapeutic agents to patients.
    Type: Application
    Filed: January 27, 2020
    Publication date: August 20, 2020
    Inventors: Wesley H. DeHaan, Jean C. Sung, Diana Manzanedo, Ciaran Lawlor, Michael Tauber
  • Methods for producing respirable dry powders
    Patent number: 10589039
    Abstract: The invention related to dry powders that contain a therapeutic agent. The dry powders have characteristics, e.g., they are processable and/or dense in therapeutic agent that provide advantages for formulating and delivering therapeutic agents to patients.
    Type: Grant
    Filed: April 24, 2017
    Date of Patent: March 17, 2020
    Assignee: Pulmatric Operating Company, Inc.
    Inventors: Wesley H. DeHaan, Jean C. Sung, Diana Manzanedo, Ciaran Lawlor, Michael Tauber
  • INHALABLE DRY POWDERS
    Publication number: 20170304564
    Abstract: The invention related to dry powders that contain a therapeutic agent. The dry powders have characteristics, e.g., they are processable and/or dense in therapeutic agent that provide advantages for formulating and delivering therapeutic agents to patients.
    Type: Application
    Filed: April 24, 2017
    Publication date: October 26, 2017
    Inventors: WESLEY H. DeHAAN, JEAN C. SUNG, DIANA MANZANEDO, CIARAN LAWLOR, MICHAEL TAUBER
  • INHALABLE DRY POWDERS
    Publication number: 20150136130
    Abstract: The invention related to dry powders that contain a therapeutic agent. The dry powders have characteristics, e.g., they are processable and/or dense in therapeutic agent that provide advantages for formulating and delivering therapeutic agents to patients.
    Type: Application
    Filed: February 28, 2013
    Publication date: May 21, 2015
    Inventors: Wesley H. DeHaan, Jean C. Sung, Diana Manzanedo, Ciaran Lawlor, Michael Tauber
  • Method and device for decreasing contamination
    Patent number: 8627821
    Abstract: Methods and devices to determine rate of particle production and the size range for the particles produced for an individual are described herein. The device (10) contains a mouthpiece (12), a filter (14), a low resistance one-way valve (16), a particle counter (20) and a computer (30). Optionally, the device also contains a gas flow meter (22). The data obtained using the device can be used to determine if a formulation for reducing particle exhalation should be administered to an individual.
    Type: Grant
    Filed: July 10, 2007
    Date of Patent: January 14, 2014
    Assignee: Pulmatrix, Inc.
    Inventors: David A. Edwards, Mark J. Gabrielson, Robert William Clarke, Wesley H. Dehaan, Matthew Frederick Brande, Jonathan Chun-Wah Man
  • METHODS FOR TREATING AND PREVENTING PNEUMONIA AND VENTILATOR-ASSOCIATED TRACHEOBRONCHITIS
    Publication number: 20120058198
    Abstract: The invention relates to methods for treating bacterial infection of the respiratory tract, including pneumonias, such as ventilator-associated pneumonia, and to methods for treating ventilator-associated tracheobronchitis, comprising administering an effective amount of a salt formulation as an aerosol to the respiratory tract of an individual in need thereof. The formulations can also be used to reduce transmission of pathogen which can infect the respiratory tract, cause pneumonia or cause ventilator-associated tracheobronchitis.
    Type: Application
    Filed: March 26, 2010
    Publication date: March 8, 2012
    Applicant: PULMATRIX, INC.
    Inventors: Robert W. Clarke, Richard Batycky, Wesley H. Dehaan, David L. Hava, Michael M. Lipp, John Hanrahan